Annie Lean

Annie Lean possesses extensive experience in regulatory affairs and project management within the pharmaceutical industry. Notable positions include Regulatory Project Manager and Director of Regulatory Affairs at AstraZeneca, where Annie worked from March 2018 to March 2022, and a consultant role at AstraZeneca from June 2015 to May 2016. Annie’s career began with a Doctor of Philosophy in Pharmacology from the National University of Singapore, obtained in December 2012, complemented by experience as a Drug Safety Specialist at PAREXEL and as a Clinical Trial Project Manager at the Pharmacogenetics Laboratory of NUS. Annie’s involvement in clinical trials showcases a strong background in pharmacogenetics and drug transporters.